Tiny tools help advance medical discoveries
MIT researchers are designing tools to analyze cells at the microscale.
Professor Roger Kamm visualizes sneaky tumor cells with 3-D assay
Kamm is studying the mechanics of metastasis, the process of cancer-cell migration from one location in the body to another and the cause of more than 90 percent of cancer deaths.
Improving the accuracy of cancer diagnoses
New spectroscopy technique could help doctors better identify breast tumors.
New technology may enable earlier cancer diagnosis
Nanoparticles amplify tumor signals, making them much easier to detect in the urine.
Tissue engineering: Growing new organs, and more
Research could lead to better ways to heal injuries and develop new drugs.
On the hunt for rare cancer cells
Jellyfish-inspired device that rapidly and efficiently captures cancer cells from blood samples could enable better patient monitoring.
How cancer cells break free from tumors
New MIT study identifies adhesion molecules key to cancer’s spread through the body.
How better financing could help create new cancer drugs
MIT finance researchers say a diversified ‘megafund’ of securities could help the industry deliver new products to consumers.
Turning on key enzyme blocks tumor formation
Drug-like molecule restores normal cell metabolism, preventing cancer cells from growing.
New nanoparticles shrink tumors in mice
Particles that shut off cancer genes could also allow researchers to screen potential drug targets more rapidly.
New drug candidate shows promise against cancer
Platinum compound may offer an alternative to cisplatin, a widely used chemotherapy agent.
Study identifies enzymes needed to mend tissue damage after inflammation
Findings may help predict colon cancer risk for patients with inflammatory bowel disease.
How infection can lead to cancer
New MIT study offers comprehensive look at chemical and genetic changes that occur as inflammation progresses to cancer.
Researchers achieve RNA interference, in a lighter package
Pared-down nucleic acid nanoparticle poses less risk of side effects, offers better targeting.
One-two punch knocks out aggressive breast cancer cells
New MIT study shows that staggered delivery of cancer drugs is far more effective than administering them at the same time.